These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 316979)
1. Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy. Chretien PB; Lipson SD; Makuch RW; Kenady DE; Cohen MH Ann N Y Acad Sci; 1979; 332():135-47. PubMed ID: 316979 [No Abstract] [Full Text] [Related]
2. Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course. Lipson SD; Chretien PB; Makuch R; Kenady DE; Cohen MH Cancer; 1979 Mar; 43(3):863-70. PubMed ID: 218717 [No Abstract] [Full Text] [Related]
3. Clinical trials with thymosin. Costanzi J; Daniels J; Thurman G; Goldstein A; Hokanson J Ann N Y Acad Sci; 1979; 332():148-59. PubMed ID: 394635 [No Abstract] [Full Text] [Related]
4. T-cell levels and response to thymosin in vitro during intensive chemotherapy in cancer patients receiving thymosin. Goldberg NH; Lipson SD; Kenady DE; Simon RM; Cohen MH; Chretien PB Surg Forum; 1977; 28():151-2. PubMed ID: 214880 [No Abstract] [Full Text] [Related]
5. Immunotherapy of cancer with thymosin. Rossio JL; Goldstein AL World J Surg; 1977 Sep; 1(5):605-16. PubMed ID: 602234 [No Abstract] [Full Text] [Related]
6. Thymosin reconstitution of T cell deficits in vitro in cancer patients. Kenady DE; Chretien PB; Potvin C; Simon RM Cancer; 1977 Feb; 39(2):575-80. PubMed ID: 300039 [TBL] [Abstract][Full Text] [Related]
7. T-cell stimulator undergoes diverse testing. Gunby P JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781 [No Abstract] [Full Text] [Related]
8. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy. Chretien PB; Lipson SD; Makuch R; Kenady DE; Cohen MH; Minna JD Cancer Treat Rep; 1978 Nov; 62(11):1787-90. PubMed ID: 215307 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation. Taylor SG Med Pediatr Oncol; 1982; 10(2):171-4. PubMed ID: 6978456 [TBL] [Abstract][Full Text] [Related]
10. The effect of thymosin on patients with disseminated malignancies. A phase I study. Costanzi JJ; Gagliano RG; Delaney F; Harris N; Thurman GB; Sakai H; Goldstein AL; Loukas D; Cohen GB; Thomson PD Cancer; 1977 Jul; 40(1):14-9. PubMed ID: 141974 [TBL] [Abstract][Full Text] [Related]
11. [Formation of immune rosettes by the cells of certain lymphoid system formations after treatment with thymosin]. Selezneva TN; Kamenets LIa; Grinevich IuA Fiziol Zh (1978); 1979; 25(6):730-4. PubMed ID: 315887 [No Abstract] [Full Text] [Related]
12. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer. Marshall GD; Thurman GB; Low TL; Goldstein AL Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies with thymosin in cancer patients. Schafer LA; Goldstein AL; Gutterman JU; Hersh EM Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916 [TBL] [Abstract][Full Text] [Related]
18. Research with immunoactive agents. Gunby P JAMA; 1981 Jul; 246(3):205. PubMed ID: 7017181 [No Abstract] [Full Text] [Related]
19. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer. Goldstein AL Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140 [No Abstract] [Full Text] [Related]